微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2024-09-30 | 1.91% | 260.57% | 87.35% | 100/160 | 4.14% | 百利天恒 | 186.1% | 行业排名> |
| 2024-06-30 | 1.02% | 5000% | 200% | 102/160 | 2.6% | 百利天恒 | 186.89% | 行业排名> |
| 2024-03-31 | 0.34% | 240% | 140% | 108/160 | 2.3% | 百利天恒 | 188.56% | 行业排名> |
| 2023-12-31 | -0.85% | 93.4% | -260.38% | 109/160 | -0.96% | 小方制药 | 41.8% | 行业排名> |
| 2023-09-30 | 0.53% | -14.52% | 2550% | 115/160 | 2.37% | 拓新药业 | 20.51% | 行业排名> |
| 2023-06-30 | 0.02% | -91.3% | -80% | 116/160 | 1.51% | 拓新药业 | 19.87% | 行业排名> |
| 2023-03-31 | 0.1% | -54.55% | 100.78% | 118/160 | 1.38% | 拓新药业 | 19.91% | 行业排名> |
| 2022-12-31 | -12.87% | -1488.89% | -2175.81% | 130/160 | 0.8% | 小方制药 | 55.57% | 行业排名> |
| 2022-09-30 | 0.62% | 113.79% | 169.57% | 111/160 | 2.89% | 福元医药 | 25.41% | 行业排名> |
| 2022-06-30 | 0.23% | 146.94% | 4.55% | 114/160 | 2.24% | 小方制药 | 34.81% | 行业排名> |
| 2022-03-31 | 0.22% | 123.4% | 127.16% | 112/160 | 1.61% | 退市金泰 | 10.74% | 行业排名> |
| 2021-12-31 | -0.81% | 25% | -379.31% | 115/160 | 0.94% | 人福医药 | 6.82% | 行业排名> |
| 2021-09-30 | 0.29% | -88.35% | 159.18% | 116/160 | 4.53% | 小方制药 | 71.99% | 行业排名> |
| 2021-06-30 | -0.49% | -388.24% | 47.87% | 118/160 | 2.99% | 汇宇制药 | 39.25% | 行业排名> |
| 2021-03-31 | -0.94% | -180.34% | 12.96% | 115/160 | 2.52% | 汇宇制药 | 28.14% | 行业排名> |
| 2020-12-31 | -1.08% | -152.43% | -143.37% | 114/160 | 3.74% | 哈三联 | 27.17% | 行业排名> |
| 2020-09-30 | 2.49% | 49.1% | 1364.71% | 90/160 | 3.22% | 汇宇制药 | 55.94% | 行业排名> |
| 2020-06-30 | 0.17% | -82.83% | -85.47% | 107/160 | 4.24% | 河化股份 | 45.32% | 行业排名> |
| 2020-03-31 | 1.17% | 108.93% | -43.2% | 66/160 | 2.24% | 汇宇制药 | 31.9% | 行业排名> |
| 2019-12-31 | 2.06% | 456.76% | 23.35% | 111/160 | 2.78% | 誉衡药业 | 35.56% | 行业排名> |
| 2019-09-30 | 1.67% | 15.97% | 68.69% | 97/160 | 7.61% | 奥赛康 | 35% | 行业排名> |
| 2019-06-30 | 0.99% | 3.13% | 76.79% | 101/160 | 5.05% | 奥赛康 | 28.15% | 行业排名> |
| 2019-03-31 | 0.56% | 12% | 51.35% | 93/160 | 2.46% | 宏源药业 | 21.91% | 行业排名> |
| 2018-12-31 | 0.37% | -9.76% | -74.31% | 117/160 | 7.09% | 奥赛康 | 9.7% | 行业排名> |
| 2018-09-30 | 1.44% | 251.22% | 50% | 95/160 | 7.26% | 奥赛康 | 40.69% | 行业排名> |
| 2018-06-30 | 0.96% | 200% | 92% | 96/160 | 4.65% | 信立泰 | 25.93% | 行业排名> |
| 2018-03-31 | 0.5% | 100% | 21.95% | 90/160 | 2.55% | 昂利康 | 15.91% | 行业排名> |
| 2017-12-31 | 0.41% | 142.27% | 0% | 117/160 | 9.66% | 奥赛康 | 12.08% | 行业排名> |
| 2017-09-30 | 0.41% | -66.67% | 28.13% | 94/160 | 8.31% | 一品红 | 31.62% | 行业排名> |
| 2017-06-30 | 0.32% | -21.95% | 28% | 100/160 | 5.59% | 丽珠集团 | 49.43% | 行业排名> |
| 2017-03-31 | 0.25% | -3.85% | 125.77% | 79/160 | 2.1% | 河化股份 | 54.24% | 行业排名> |
| 2016-12-31 | -0.97% | -2040% | -178.86% | 109/160 | 6.33% | 华东医药 | 7.2% | 行业排名> |
| 2016-09-30 | 1.23% | 105% | 200% | 72/160 | 5.61% | 南新制药 | 81.7% | 行业排名> |
| 2016-06-30 | 0.41% | -26.79% | 57.69% | 81/160 | 3.53% | 德展健康 | 29.5% | 行业排名> |
| 2016-03-31 | 0.26% | -23.53% | 420% | 71/160 | 2.65% | 贝达药业 | 16.78% | 行业排名> |
| 2015-12-31 | 0.05% | 109.26% | -91.67% | 93/160 | 11.35% | 河化股份 | 19.29% | 行业排名> |
| 2015-09-30 | 0.6% | 87.5% | 7.14% | 71/160 | 7.22% | 一品红 | 58.17% | 行业排名> |
| 2015-06-30 | 0.56% | 1020% | 64.71% | 70/160 | 4.9% | 华东医药 | 36.97% | 行业排名> |
| 2015-03-31 | 0.34% | 112.5% | 162.96% | 64/160 | 2.41% | 华东医药 | 26.63% | 行业排名> |